Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Late effects after chemotherapy].

W Pönisch1, D Niederwieser

  • 1Abteilung Hämatolgie/Onkologie, Medizinische Klinik und Poliklinik II, Universitätsklinikum Leipzig AöR, Leipzig. nied@medizin.uni-leipzig.de

Der Internist
|February 14, 2006
PubMed
Summary

Cancer survivors often face long-term health issues, with many experiencing severe or life-threatening late effects. This review summarizes common late effects in cancer survivors based on recent research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020
Same author

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020
Same author

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

Hematology/oncology and stem cell therapy·2019
Same author

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis.

Journal of internal medicine·2018
Same author

[Autoimmune reactions to immune checkpoint inhibitors].

Zeitschrift fur Rheumatologie·2018
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017

Area of Science:

  • Oncology
  • Cancer Survivorship Research

Background:

  • Significant advancements in cancer treatment have improved survival rates for both adults and children.
  • A substantial proportion of cancer survivors experience long-term health complications, known as late effects.

Purpose of the Study:

  • To provide an overview of typical late effects experienced by cancer survivors.
  • To synthesize findings from recent publications on cancer survivorship.

Main Methods:

  • Literature review of recent publications.
  • Synthesis of data on cancer survivorship and late effects.

Main Results:

  • Approximately 60% of adult and 80% of child cancer patients survive 5 years post-diagnosis.
  • Two-thirds of survivors encounter at least one late effect; one-third face severe or life-threatening complications.

Conclusions:

  • Modern cancer treatment aims to cure malignancy while minimizing post-treatment complications.
  • Understanding and managing late effects is crucial for improving the quality of life for cancer survivors.

Related Experiment Videos